Vocal biomarkers Market will Reflecting a CAGR of 14.5% by 2023

 Vocal biomarkers are a novel technique developed to detect the presence of disease from speech characteristics. By decoding the vocal intonations in real-time, the technology can provide holistic treatment and quality patient care. The global vocal biomarkers market report by Market Research Future (MRFR) highlights several developments which can assist diseases combined with supporting drivers and restraints for the period of 2017 and 2023 (forecast period). 

FREE SAMPLE COPY OF “Vocal Biomarkers Market Research Report- Global forecast till 2023”@

https://www.marketresearchfuture.com/sample_request/3933

Market Outlook

The global vocal biomarkers market is bound to touch a valuation of USD 2.5 billion by 2023. It can exhibit a CAGR of 14.3% during the forecast period. It is driven the prevalence of various neurological and psychological diseases such as Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, depression, attention deficit and disruptive behavior disorders, traumatic brain injury, and others. According to the WHO, close to 350 million suffered from depression in 2016 and the Parkinson’s disease Foundation estimated the number of patients affected by the disease to be reaching a number of 10 million in the same year.

Various government organizations are partnering up with private clinics and firms to develop machine learning algorithms for initial detection of diseases. This is exemplified by the alliance of American Heart Association with Mayo Clinic and Beyond Verbal to use voice patterns to detect coronary heart disease at its initial stage. Development of smartphone applications to detect all disease from voice or sounds can provide the global vocal biomarkers the much-needed impetus in the coming years.

Segmentation Analysis

The global vocal biomarkers market is segmented by type, indication, and end-user.

The global market, by type is segmented into pitch, voice tremor, vocal rise or fall time, phonation time, error rate, amplitude, frequency, and others.

The market, by indication, is segmented into neurological disorders, psychiatric disorders, cardiovascular disorders, respiratory disorders, and others.

Based on end-user, the market is segmented into academic and research, hospitals and clinics, and others.

Regional Analysis

The Middle East & Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are major regions in the global vocal biomarkers market.

The Americas is predicted to dominate the global market due to the U.S. grabbing maximum shares owing to large healthcare expenditure and favorable reimbursement schemes. The fast adoption rate of new technology can be pivotal in driving the vocal biomarkers market. Alternatives to MRI/CT/EEG machines will find demand due to the large elderly populace in the region.

Europe is the second-biggest region for the market due to large awareness levels and expendable income levels of patients. In addition, the need for non-invasive techniques for detection of diseases is ensured to gain traction and pave way for the global vocal biomarkers market. 

The APAC region is expected to have the largest potential for the market due to the large patient pool in China and India. On the other hand, the MEA region will contribute to the vocal biomarkers market due to the booming medical sector in Saudi Arabia and UAE.

Competitive Outlook

Audio Profiling, Sonde Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and others are reputed companies currently operating in the global vocal biomarkers market.

Industry Update

Sonde Health has managed to raise close to USD 16 million in series A funding to spur the development of vocal biomarkers. The technology has amassed hundreds of vocal characteristics from recordings to identify changes in pitch, rate of speech, and hoarseness to assess health. 

Aural Analytics has published the results of a clinical trial involving the effects of reldesemtiv, a skeletal muscle troponin activator, used in the treatment of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). The company analyzed vocal biomarkers for the duration of the trial to notice any improvements in speech patterns.

Click here to get the short-term and long-term impact of COVID-19 on this Market: https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                

Akash Anand                                                                    

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Lymphedema Diagnostics Market Growing Demand, Share, Technologies and

 Lymphedema Diagnostics Market Overview:

The global market for the lymphedema diagnostics market has been projected to surpass a market valuation of USD 37.6 million by 2025 at a 7.1% CAGR during the forecast period of 2019 to 2025. Market Research Future (MRFR) revealed that the market could benefit from several factors like the high prevalence of the diseases, growing instances of cancer, better diagnostic facilities and demand for early diagnosis, hike in awareness level, increasing inclusion of technologies to widen the testing opportunities, investment for research and development procedures, and others. 

Free Sample Copy of Lymphedema Diagnostics Market With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/8761

However, the market may suffer due to the short half-life of radiopharmaceuticals. Also, the high cost of diagnostic tests can deter the market from having a smooth growth during the forecast period.

Lymphedema Diagnostics Market Segmentation:

The global report on the lymphedema diagnostics market can be segmented into type, technology, end user, and disease type. MRFR analysts have included these segments and supported their claims with figures, charts, and graphs. 

By technology, the global market report on the lymphedema diagnostics market can be segmented into magnetic resonance imaging, lymphoscintigraphy, ultrasound imaging, computed tomography, and others. The lymphoscintigraphy segment has the maximum market share. 

By disease type, the global study includes segments like cancer, cardiovascular diseases, inflammatory diseases, and others. The cancer segment has the maximum market share.

By type, the global market can be segmented into primary and secondary. The secondary segment has the maximum market share.

By end user, the global report on the lymphedema diagnostics market can be segmented into hospitals, diagnostics centers, and others. In 2018, it was the hospital segment with the maximum market share. 

Lymphedema Diagnostics Market Regional Analysis:

The Americas is impacting the global market with the lion’s share of the revenues that they earn from the investment taking place in mainly countries like the US and Canada. These two countries and their robust infrastructure would ensure better growth for the market. Asia Pacific would register the fastest growth during the forecast period. 

Lymphedema Diagnostics Market Competitive Landscape:

Siemens Healthineers, GE Healthcare, Stryker Corporation, Philips, Shimadzu Corporation, Canon, Inc., United Imaging Healthcare Co., Ltd., Hitachi, Ltd., and Fluoptics are some of the major companies involved in the global lymphedema diagnostics market. These companies are impacting the market growth with their top-class strategic measures that often span across types like merger, acquisition, innovation, increased funding for research and development, collaboration, branding, launching of the product, and others. MRFR recorded these moves to understand how the market may get impacted and what trends would take charge of the global market in the coming years. 

Industry News:

In June 2020, an Australian medical device maker with the permission for a device that can detect lymphedema inked a national purchase agreement with the U.S. Oncology Network. The latter is a Texas-based group with over 1,200 physicians across 470 locations. It is also a subsidiary of McKesson Corporation. Lymphedema is a type of disease where swelling takes place in arms and legs and can be a side-effect of some cancer treatments. If diagnosed early, this can be treated with good results, but its impact cannot be wholly reversed in its later stages. 

In February 2020, ImpediMed Limited (ASX.IPD), a medical software technology company, known for its non-invasive processes of measuring, monitoring, and managing of fluid status and tissue composition by using bioimpedance spectroscopy (BIS), announced that the NCCN Clinical Practice Guidelines for Breast Cancer (NCCN Guidelines®) included new recommendations for early detection and diagnosis of lymphedema to in their latest guideline to achieve optimal management.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/lymphedema-diagnostics-market-8761

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Diagnostic Electrocardiograph (ECG) Market Overview by 2020 | Global Analysis to Forecast by 2025

 Diagnostic Electrocardiograph (ECG) Market Overview

Populations with heart-related disorders are increasing. Diagnostic electrocardiograph (ECG) is a device for observing the heart activity, which helps the observer record the behavior. Being a minimally invasive technique, it has gained a huge response from the practitioners are patients. The rapid development in diagnostic techniques and rising heart-related disorders due to unhealthy lifestyles and habits have boosted the market. Also, the rise in demand for early detection technologies has increased the usage and adoption of ECG.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8787

As the geriatric population increases, regular heart observation has required, which has propelled the market at much greater speeds. After observing ECG technology's capabilities, the healthcare facilities are rapidly adopting this technology, which has led to an increase in healthcare budgets and has increased the market's global share. Also, the companies are readily investing in the research & development programs to unfold new segments of this market, like the introduction of devices with maximum accuracy.

Apart from the uses and features, the global diagnostic electrocardiograph market is facing friction from factors like struggling economic structures and scarcity of trained professionals, which has degraded the market's growth rates. This report will shed light on the competition, opportunities, drivers & restraints, and other factors affecting the local and global diagnostic electrocardiograph (ECG) market. The global market is expected to register nearly a 06 % annual growth rate during the survey.

Diagnostic Electrocardiograph (ECG) Market division

The global diagnostic electrocardiograph (ECG) market is segmented into classes as follows:

The global diagnostic electrocardiograph market is segmented into stress ECG devices, smart ECG monitors, rest ECG devices, and others based on product types.

The global diagnostic electrocardiograph market divided into the single lead, 3 lead, 5 lead, and other devices based on lead type.

Based on end-users, the global diagnostic electrocardiograph market is segmented into hospitals, clinics, and others.

Diagnostic Electrocardiograph (ECG) Market Regional Classification

Diagnostic Electrocardiograph (ECG) has gained global adoption worldwide due to the demands for better healthcare technologies and increasing healthcare budgets globally. The Asia Pacific, North America, Europe, and the rest of the world are the major market studies for the global Diagnostic Electrocardiograph (ECG) market. The North American region is leading the market due to demands for better alternatives, well-established healthcare facilities, and other factors. On the other hand, the Asia Pacific region will file the fastest growth rate due to rapidly developing the healthcare system, rising government initiatives increasing research & development programs, demands for better healthcare alternates, vast population covers, rise in old age populations, and other factors.Industry News

The global diagnostic electrocardiograph market has become an important part of the healthcare system as the heart is the life o

Read Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-electrocardiograph-market-8787

f the human body and needs intensive care and monitoring. The authorities have reacted actively to these devices as they are capable of early detection of related disorders and are non-invasive, which has forced them to invest and increase the healthcare budgets. The global market is led by the North American region, followed by the European region, whereas the Asia Pacific region will register the highest growth rates.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

News: Diabetes Monitors Market Top companies | analysis | Regional Forecast

 

Market Highlights

Market Research Future (MRFR) evaluated the diabetes monitors market 2020 for the forecast period 2017-2023. By 2023, the diabetes monitor market can rise at 8.3% CAGR.

The increase in low fiber food intake is leading to rise in metabolic diseases. Among these, most are diabetic patients. Along with the rise in cases of type 1 diabetes, type 2 diabetes cases are also observed to peak. Diabetes is a silent killer and requires periodic check-up. Often, frequent visit to clinics becomes tedious. Hence, are large number of patients prefer diabetes monitor that can check blood glucose level at home. At the same time, to monitor types of diabetes and also, gestational diabetes, hospitals and clinics highly rely on diabetes monitors. Other type of diabetes, such as monogenic diabetes and cystic fibrosis-related diabetes can also be checked by diabetes monitors. These are some factors that are observed to promote the expansion of the diabetes market in the years ahead. Other causes that can favor the   diabetes monitoring market are technological innovations, hefty research funds, rise in diabetes cases, rapid approval by regulatory bodies, and expansion of world obesity population. On the contrary, high diagnosis and treatment expense for diabetes, and lack of good reimbursement policies can limit the diabetes monitors market rise in the years to come.

Get Latest Free Sample Copy With Covid19 Impact @ https://www.marketresearchfuture.com/sample_request/4781

Market Segmentation

 

The segment assessment of the diabetes monitors market is done by type, sample, end-users, and component.

The sample based segment of the diabetes monitors market are sweat samples, blood samples, and urine samples among others.

The type based segment of the diabetes market are continuous glucose monitors (CGM), point sample test based glucose monitors, and enzyme free sensor based glucose monitors. The continuous glucose monitors are used largely. Re-usable sensor-based and Disposable sensor-based are two popular types of CGM.

The component based segment of the diabetes monitor market are sensors, lancet, and glucose test strips. Sensors sub-segments are enzyme-free sensors and enzyme-based sensors.

The end –users based segment of the diabetes monitor market are hospitals, diagnostic clinics, and home. The home segment to earn decent revenue for the world market.

 

Regional Analysis

 

Trends of the diabetes monitors market is assessed across EU, the Americas, APAC, and the MEA. The expansion of the diabetes patient in North America due to sedentary life style and high intake of low fiber content diet can tout North America diabetes monitor market in the analysis period. According to National Diabetes Statistics Report, a considerable population of the U.S. has type 1 diabetes. In addition, increase in cases of type 2 diabetes in the region is also creating the demand for diabetes monitors. These are identified as factors that can boost the regional market in the analysis period. In Europe, the diabetes monitor market can earn high revenue in the approaching years due to similar growth factors that are observed in North America. In addition, the rise in support from the regional government are observed to make substantial investment in the healthcare domain for effective innovations that can improve the momentum of Europe market. In Asia Pacific, the rise in the need for cost-effective glucose monitoring devices by the large pool of patient can drive the expansion of the regional diabetes monitor market. In MEA, the market can experience moderate growth as technical development in the region is yet to match the rest of the World.

Major Key Players

MRFR lists some noteworthy diabetes monitor marketers. They are; Abbott Laboratories, Panasonic, Dexcom, Inc., F. Medtronic, Hoffmann-La Roche Ltd, Sanofi, and LifeScan, Inc.

Read  More @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Global High potency Body Contouring Devices and Procedures Market Industry Size, Growth, Opportunities, Outlook and Forecast 2023

 Market Highlights:

The Global Body Contouring Devices and Procedures Market.  held a market value of USD 2,103 million in 2017 and is projected to grow at a CAGR of 6.6% over the forecast period.Body contouring is a altering the body part by improving the appearance. It involves the removal or transfer of fat to the body.  

Get sample Copy @ https://www.marketresearchfuture.com/sample_request/6935 

Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of urgery with advanced technologies may hamper the market growth during the assessment period.

Regional Analysis:

On regional basis, the Americas is anticipated to dominate the global  [URL=https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935]body contouring devices and procedures market size[/URL]  owing to the growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.  Europe is expected to hold the second largest position in the global body contouring devices and procedures market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Asia Pacific has served an opportunity for developing body contouring market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity. The Middle East & Africa has the least share of the global body contouring devices and procedures market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation:

The global body contouring devices and procedures market has been segmented into type, procedure, and end user. By type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. The non-invasive & minimally invasive devices segment is estimated to hold major market share in the global body contouring devices and procedures market due to the huge investments by major market players for the development of advanced technologies and equipment.

Based on procedure, the market has been segmented into non-surgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. The market, by end user, has been segmented into hospitals & clinics, research institutes & Organization, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935 

Key Players:

Some of the prominent players in the global body contouring devices and procedures market are Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd, Bausch Health Companies, Inc, Lumenis, Merz Pharma GmbH & Co., Palomar Medical Technologies Inc., Sound Surgical Technologies LLC., Zeltiq Aesthetics, Chromogenex Technologies LTD, UltraShape Ltd, Fotona, Misonix Inc., Medicis Pharmaceutical Corporation, Sientra Inc., Invasix Ltd, Erchonia Inc, Lutronic.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Global Analysis On AI in drug discovery Market (2020-2023)

 

The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height. 

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes. 

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery. 

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market. 

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type    : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology       : Machine Learning, Deep Learning, and others.

By Indication          : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application       : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User            : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions               : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

 

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI applications in drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market   - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.  

Browse Complete Report @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

 

Major Players: 

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:       

Akash Anand           

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Kidney Dialysis Equipment Market 2020 | trends

 Kidney Dialysis Equipment Market Overview

Worldwide kidney dialysis equipment market is likely to accrue USD 16.5 billion over the forecast period 2018-2023. The market has been expected to expand at 5.7% CAGR during 2018-2023. Chronic kidney disease or CKD is a chronic condition which critically affects a patient’s life quality. Kidney dialysis is the most preferred cure for serious conditions where both the kidneys of a person is damaged. However, this treatment is also sporadically used for curing patients with a single damaged kidney. On average, the kidney of a fit person filters about 150 quarts of blood per day. When the kidney fails to perform efficiently, the waste automatically gathers in the blood resulting in coma and even death. In such cases, dialysis acts as the savior. It prevents the waste and toxin products formation in the blood. Dialysis acts as an artificial kidney that finds wide application in filtering the patient’s blood during kidney damage, kidney dysfunction, kidney failure, and for eliminating surplus impurities from kidneys. Improved healthcare infrastructure, growth in the prevalence of dialysis patients, loss of appetite resulting weight loss, embracing updated technologies in dialysis, adoption of sedentary lifestyle, increasing acidosis, heart failure, and surging number of ESRD (End Stage Renal Disease Patients) drive the kidney dialysis equipment market to a great extent. Additionally, cost-effective portable dialysis device, rapidly growing geriatric population, rising frequencies of diabetes and hypertension issues and preference for dialysis over kidney transplantation. However, the risks and difficulties involved, soaring cost of dialysis procedures, rules and regulations pertaining to dialysis, costly cures, and time consumption are likely to propel the growth of the kidney dialysis equipment market over the forecast period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6302

Kidney Dialysis Equipment Market Segmentation

The worldwide kidney dialysis equipment market has been segmented based on apparatus type, end-user, and type.

Based on apparatus type, the kidney dialysis equipment market has been segmented into peritoneal dialysis device, consumables, hemodialysis apparatus, and continuous renal replacement therapy systems. The hemodialysis equipment has been sub-segmented into tunneled hemodialysis catheters, vascular access devices, bloodline system, solutions, filters, concentrates, dialyzers and hemodialysis machine. The peritoneal dialysis equipment has been sub-segmented into dialyzers, filters, concentrates, solutions, and automated peritoneal dialysis devices. Of these, the hemodialysis equipment market is likely to hold the major market share.

Based on end-user, the kidney dialysis equipment market has been segmented into home care, ambulatory services, hospitals, and in-center dialysis settings.

Based on type, the kidney dialysis equipment market has been segmented into peritoneal dialysis, hemodialysis, and Continuous Renal Replacement Therapy (CRRT). Hemodialysis has been sub-segmented into short daily hemodialysis, conventional hemodialysis, and nocturnal hemodialysis. The Peritoneal dialysis has been sub-segmented into Continuous Cycling Peritoneal Dialysis (CCPD), Intermittent Peritoneal Dialysis (IPD), Tidal Peritoneal Dialysis, and Continuous Ambulatory Peritoneal Dialysis (CAPD).

Kidney Dialysis Equipment Market Regional Analysis

Geographically, the kidney dialysis equipment market has been segmented across Europe, North America, Middle East and Africa, and Asia Pacific. North America has been anticipated to dominate the market owing to the growing prevalence of kidney failure, hypertension, increasing cases of diabetes and surged reusable income within the population. Europe represents the second largest market owing to progressive medical compensation and advanced organizations. The kidney dialysis device market in APAC possess an unparalleled market prospect on account of the growing instances of kidney failure, rise in disposable income, low rates of organ transplantation, and prevalence of aged population. The Middle East and Africa have minimal share in the global kidney dialysis equipment market owing to low per capita income and stringent government policies.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/kidney-dialysis-equipment-market-6302

Kidney Dialysis Equipment Market Key Players

The global kidney dialysis equipment market has been dominated by key players such as Teleflex Incorporated, Hemoclean CO., LTD, Terumo Corporation, Rockwell Medical, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Nxstage Medical, Inc., Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Diaverum Deutschland GmbH, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. Ka., and Davita Healthcare Partners Inc.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com